BioSpace News Archive

Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, government and military use, announced that on September 30, 2021, the Company granted stock options to five new employees of the Company.

Adverum Biotechnologies, Inc. (Nasdaq: ADVM), today announced new long-term data from the OPTIC clinical trial of ADVM-022 single, in-office intravitreal (IVT) injection gene therapy in patients requiring frequent anti-VEGF injections for their neovascular or wet age-related macular degeneration (wet AMD).

MEI Pharma, Inc., a late-stage pharmaceutical company focused on advancing new therapies for cancer, announced the grant of inducement stock options for an aggregate of 136,000 shares of the company’s common stock to three new employees.

Natus Medical Incorporated, a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced that the Company will release its 2021 third quarter financial results after the close of the market on Thursday, November 4th.

Baudax Bio, Inc. announced that the Compensation Committee of Baudax Bio’s Board of Directors approved inducement grants of stock options to purchase an aggregate of 242,688 shares of Baudax Bio’s common stock and restricted stock units covering 79,385 shares of Baudax Bio’s common stock to 22 newly-hired employees, with a grant date of September 30, 2021.

INVO Bioscience, Inc. today announced that it has entered into definitive agreements with institutional and accredited investors and members of INVO Bioscience’s management team to purchase 1,240,763 shares of its common stock

BioFluidica™, a privately held biotechnology company, today announced the publication of promising new data from its collaboration with Wright State University and Premier Heath, Dayton, Ohio, in the journal Prenatal Diagnosis. It shows that chromosome abnormalities (aneuploidy) can be identified in fetal cells isolated from maternal circulation during pregnancy using BioFluidica’s high-throughput, high-sensitivity microfluidic system, the LiquidScan™.

IQ-AI Limited, a developer and manufacturer of medical image processing platforms announced a recent publication in Neurosurgery Open that illustrates the clinical impact of its neuro oncology software solutions for both neurosurgery and tissue diagnosis of high-grade brain tumors.

Doubling down on efforts to prepare highly qualified young scientists for a career in immune disease-focused medical research, The Feinstein Institutes for Medical Research, the science arm of Northwell Health, has been awarded a multi-year National Institutes for Health grant totaling $1.5 million.

Carlsmed, Inc., announced today the U.S. launch of the aprevo® patient-specific spine technology and the New Technology Add-On Payment (NTAP) reimbursement.